A Phase I Study of TQ-B3395 on Tolerance and Pharmacokinetics

NCT02944864 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

53

Enrollment

INDUSTRY

Sponsor class

Stopped Per sponsor request.

Conditions

Advanced Cancer

Interventions

DRUG: TQ-B3395

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.